Literature DB >> 6193730

Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.

M Scheinin, W H Chang, K L Kirk, M Linnoila.   

Abstract

An improved high-performance liquid chromatographic method with electrochemical detection (HPLC-EC) for the simultaneous determination of 3-methoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxyindoleacetic acid (5-HIAA), and homovanillic acid (HVA) in cerebrospinal fluid (CSF) of humans and nonhuman primates is described. Quantitation is based on the use of an internal standard, 5-fluoro-HVA. Sample preparation consists of mixing an aliquot of CSF with a solution of the internal standard followed by ultrafiltration. The precision of the method is high, with within-run and between-run coefficients of variation of 2-6% and less than 10%, respectively, in the concentration ranges of the metabolites encountered in human lumbar CSF. Accuracy was tested by comparing the present HPLC method with specific gas chromatographic-mass spectrometric (GS-MS) assays for MHPG and HVA and a GC-MS-validated HPLC assay for 5-HIAA: the correlations obtained were 0.968 for MHPG, 0.989 for 5-HIAA, and 0.999 for HVA, with no systematic bias between the methods. The use of ascorbate as a preserving agent for monoamine metabolites in CSF was not found to be necessary when proper care was exercised in sample handling and storage. The analysis of samples with up to 2% ascorbic acid was possible as well, but MHPG had to be assayed separately using an extraction procedure and an alternative internal standard, 3-ethoxy-4-hydroxyphenylglycol.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193730     DOI: 10.1016/0003-2697(83)90162-8

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  24 in total

1.  Nonhuman primate model of alcohol abuse: effects of early experience, personality, and stress on alcohol consumption.

Authors:  J D Higley; M F Hasert; S J Suomi; M Linnoila
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  Changes in plasma levels of BDNF and NGF reveal a gender-selective vulnerability to early adversity in rhesus macaques.

Authors:  Francesca Cirulli; Nadia Francia; Igor Branchi; Maria Teresa Antonucci; Luigi Aloe; Stephen J Suomi; Enrico Alleva
Journal:  Psychoneuroendocrinology       Date:  2008-10-11       Impact factor: 4.905

3.  Cerebrospinal Fluid Levels of Monoamine Metabolites in the Epileptic Baboon.

Authors:  C Ákos Szabó; Mayuri Patel; Victor V Uteshev
Journal:  J Primatol       Date:  2015-10-14

4.  Maternal neglect and the serotonin system are associated with daytime sleep in infant rhesus monkeys.

Authors:  Alexander Baxter; Elizabeth K Wood; Christina S Barr; Daniel B Kay; Stephen J Suomi; J Dee Higley
Journal:  Dev Psychopathol       Date:  2020-02

5.  Seasonality of cerebrospinal fluid monoamine metabolite concentrations and their associations with meteorological variables in humans.

Authors:  Timothy D Brewerton; Karen T Putnam; Richard R J Lewine; S Craig Risch
Journal:  J Psychiatr Res       Date:  2018-01-12       Impact factor: 4.791

6.  Effect of clomipramine on monoamine metabolites in the cerebrospinal fluid of behaviorally normal dogs.

Authors:  C J Hewson; U A Luescher; J M Parent; R O Ball
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

7.  6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys.

Authors:  D J Doudet; H Miyake; R T Finn; C A McLellan; T G Aigner; R Q Wan; H R Adams; R M Cohen
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

8.  Effects of chlorpromazine on hypothalamic aminergic neurons and stress responses in moderate cold.

Authors:  M L Kortelainen; T Lapinlampi; J Hirvonen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

9.  Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites.

Authors:  M Hovi-Viander; J Kanto; H Scheinin; M Scheinin
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

10.  Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.

Authors:  N A Garrick; T Seppala; M Linnoila; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.